Interventional Oncology

Session: Ongoing IO Clinical Trials, Scientific Breakthroughs, and Future Opportunities: An Update

New and evolving clinical trials: embolotherapy

Wednesday, March 8, 2023

3:00 PM – 3:14 PM

Location: Phoenix Convention Center, 228AB

Speaker(s)

MS

Michael C. Soulen, MD

Director Interventional Oncology
Abramson cancer Center, University of Pennsylvania

Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)

Disclosure(s):

Michael C. Soulen, MD: Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)